DC Chemicals

All products / DC5041

DCC-2036 (Rebastinib)
CAT. NO. DC5041

DCC-2036 (Rebastinib)

Pack sizes and prices

Pack sizePrice
100 mg$500 USDRequest a quote / confirm availability →
250 mg$900 USDRequest a quote / confirm availability →
1 g$1,800 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

DCC-2036 is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1/2.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC5041
Product nameDCC-2036 (Rebastinib)
CAS1020172-07-9
Molecular formulaC30H28FN7O3
Molecular weight553.59
Purity>98%
SMILESCNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — DCC-2036 (Rebastinib) (DC5041)

Related research products

Browse newly added products